MoneyWorks4Me

Ipca Laboratories board recommends final dividend

29 May 2012 Evaluate
Ipca Laboratories has informed that the Board of Directors of the Company at its meeting held on May 29, 2012, has recommended a final dividend of Rs. 1.20 per share (60%) for the financial year ended March 31, 2012.
 
The above information is part of company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..